Loading
Latest filing published 12 May 2026 for Ascendis Pharma A/S, €3.9M. Read the official filing
No signal scores available.
One trade, one date: on 12 May 2026, Flemming Steen Jensen disclosed an open-market sale of €3.9M in Ascendis Pharma A/S. No broader history exists yet. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration